Clinical Trial Update: Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating chemosensitivity in low/intermediated-risk mid-low stage II/III rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: West China Hospital | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED